$4.99
-0.15-2.92%
Pre-Market: Feb 25, 8:41 AM EDT
Comments
Loading...
Neuphoria Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:NEUP | Benzinga
Neuphoria Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 14
EPS
$-1.230
Quarterly Revenue
$662.72K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$662.72K
Analyze the earnings history of Neuphoria Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Neuphoria Therapeutics (NEUP) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Neuphoria Therapeutics (NEUP) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Neuphoria Therapeutics (NASDAQ:NEUP) reporting earnings?
Neuphoria Therapeutics (NEUP) is scheduled to report earnings on May 15, 2025. The last reported earnings were for reported on February 14, 2025 for Q2.
What were the latest earnings per share (EPS) for Neuphoria Therapeutics (NASDAQ:NEUP)?
The Actual EPS was $-1.23, which missed the estimate of $0.00.
What were Neuphoria Therapeutics’s (NASDAQ:NEUP) revenues?
The Actual Revenue was $662.7K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.